Trial Profile

A clinical study of BT-600 in active ulcerative colitis patients

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 28 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tofacitinib (Primary)
Indications Ulcerative colitis
Focus Adverse reactions

Most Recent Events

14 Nov 2024 According to Biora Therapeutics media release, the company has concluded that the results from phase I study may support proceeding to a larger clinical trial in ulcerative colitis patients, instead of the smaller Phase 1B trial they had been planning.
28 Mar 2024 New trial record
26 Mar 2024 According to Biora Therapeutics this study is planned during the second half of 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com